awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38218209-649B4B82-D938-447F-A6B6-FB83BEBD8060
Q38218209-649B4B82-D938-447F-A6B6-FB83BEBD8060
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38218209-649B4B82-D938-447F-A6B6-FB83BEBD8060
Current Phase II investigational proteasome inhibitors for the treatment of multiple myeloma.
P2860
Q38218209-649B4B82-D938-447F-A6B6-FB83BEBD8060
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38218209-649B4B82-D938-447F-A6B6-FB83BEBD8060
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f9aef7cab8ed96072732137788f6a690703936f
P2860
An open-label single-arm pilot phase II study (PX-171-003-A0) of low-dose, single-agent carfilzomib in patients with relapsed and refractory multiple myeloma.